Portfolio company
Blueberry Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops nanomedicine therapies for patients with common dermatological and fungal infections using a proprietary delivery platform.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NovaBiotics
This biotechnology company develops anti-infective therapies and conditioning treatments for nail, skin, scalp, and hair health for patients and personal care consumers.
Destiny Pharma
This clinical-stage biotechnology company develops medicines to prevent and treat life-threatening infections for patients in healthcare settings.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
DermBiont
This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.
ASHVATTHA THERAPEUTICS
This clinical-stage biopharmaceutical company develops targeted nanomedicine therapeutics for patients with inflammatory, neurological, and ophthalmic diseases including age-related macular degeneration.
Nanna Therapeutics
The company develops medicines for mitochondrial and age-related diseases for patients with unmet medical needs.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Arcutis Biotherapeutics
This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.
